InvestorsHub Logo
Followers 16
Posts 1898
Boards Moderated 0
Alias Born 05/12/2016

Re: SavageWildlings post# 78237

Monday, 10/29/2018 7:00:13 AM

Monday, October 29, 2018 7:00:13 AM

Post# of 140475
I agree. With decades in the medical device and development realm and another decade or program management experience, I understand delays are a normal part of the process, so we may be in for another delay, but we should never know about it. It should already be baked into the current schedule.

Good program/project management knows not everything falls into place when it should, and they need to have a solid understanding of where their technology lies in terms of development risk and schedule risk. After about 9 months or so with this company, Mr. McNally's team appears to have identified these risks and made appropriate plans to ensure the released technology would be current, impactful, and have the best chance of market success. The announced delay last year was probably not only to allow incorporation of the requisite modifications, but I believe the delay he announced was a responsible and thoughtful schedule which also gave them sufficient leeway for one or two little inevitable hiccups. If there is a further delay, it should be imperceptible. If there are no delays, it means we should be coming in ahead of schedule.

Good budgeting matches the schedule, so "ahead of schedule" means "under budget."

That is how the game is played.

Side note: Congratulations Red Sox! There are a lot of things that suck about being from New England, starting with weather and traffic. It's nice that the Red Sox are no longer part of the "Why New England Sucks" list!



Message in reply to:

Yes but it seems we are still far away. There hasn’t been any mention of marketing and design freeze. This leads me to believe we are in for another delay. Just an opinion.